Thymosin Alpha-1

Zadaxin

Peptide peptide SubQ FDA/EMA Label

Half-life

2 hr

Time to Peak

1 hr

Steady State

~1 days

Dose Range

0.8–3.2 mg

Frequency

Twice weekly

Overview

Naturally occurring thymic peptide approved in over 30 countries for hepatitis B and C treatment and as an immune system modulator. One of the best-characterized therapeutic peptides with extensive clinical data. Used in the peptide community for immune optimization and general wellness. Supplied as lyophilized powder requiring reconstitution.

Mechanism of Action

Modulates T-cell maturation and function, enhances dendritic cell activity, and stimulates innate and adaptive immune responses. Increases MHC class I expression on tumor cells.

Dosing Information

Route Dose Range Half-life Tmax Frequency
Subcutaneous (SubQ) 0.8–3.2 mg 2 hr 1 hr Twice weekly, Daily

Storage & Handling

2-8C — Store lyophilized powder refrigerated. Reconstitute with provided diluent or sterile water.

Used in Regimens

1 regimen

Data Sources

  • FDA Label Zadaxin (Thymosin Alpha-1) Prescribing Information

Related Tools

Track Thymosin Alpha-1 with Doseline

Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.

Join the waitlist

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.